Research progress on dendritic cell vaccines in cancer immunotherapy

Research progress on dendritic cell vaccines in cancer immunotherapy

Abstract Dendritic cell (DC) vaccines induce specific immune responses that can selectively eliminate target cells. In recent years, many studies have been conducted to explore DC vaccination in the treatment of hematological malignancies, including acute myeloid leukemia and myelodysplastic syndrom...

Full description

Bibliographic Details
Main Authors: Jifeng Yu, Hao Sun, Weijie Cao, Yongping Song, Zhongxing Jiang
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Experimental Hematology & Oncology
Subjects:
Dendritic cell vaccine
Acute myeloid leukemia
Myelodysplastic syndrome
Cancer immunotherapy
Online Access:https://doi.org/10.1186/s40164-022-00257-2

Internet

https://doi.org/10.1186/s40164-022-00257-2

Similar Items